In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Barrx Medical: Making A Case For Ablation

Executive Summary

Barrx Medical set out seven years ago to compile enough clinical trial data to prove not only that ablation is a safe and effective way of treating Barrett's esophagus, but also that is cheaper than endoscopic surveillance. Its patience is beginning to pay off.
Advertisement

Related Content

NinePoint Medical Looks Deep For Barrett’s Esophagus
Medical Device Market & Industry Briefs, April 2012
Covidien Acquisitions Keeps Buying Spree Alive
Buyer Appetite Might Appeal To GI Device Investors
NinePoint Medical Inc.
The A-List: 2010's Trend-Shaping Series A Financings
Advancing Ablative Tumor Therapies Into Primary Treatments
Advancing Ablative Tumor Therapies Into Primary Treatments
Gastroenterology's Elusive Device Opportunity
Gastroenterology's Elusive Device Opportunity

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003554

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel